3NF9

Structural basis for a new mechanism of inhibition of HIV integrase identified by fragment screening and structure based design

3NF9 の概要

• エントリーDOI: 10.2210/pdb3nf9/pdb
• 関連するPDBエントリー: 1bhl 1bi4 1biu 1ex4 1k6y 3NF6 3NF7 3NF8 3NFA
• 分子名称: Integrase, SULFATE ION, 5-[(6-chloro-2-oxo-2,3-dihydro-1H-indol-1-yl)methyl]-1,3-benzodioxole-4-carboxylic acid, ... (6 entities in total)
• 機能のキーワード: integrase, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor
• 由来する生物種: Human immunodeficiency virus 1
• タンパク質・核酸の鎖数: 2
• 化学式量合計: 42321.95

構造登録者

Peat, T.S.,Newman, J.,Deadman, J.J.,Rhodes, D. (登録日: 2010-06-10, 公開日: 2011-04-27, 最終更新日: 2024-03-20)

主引用文献

Rhodes, D.I.,Peat, T.S.,Vandegraaff, N.,Jeevarajah, D.,Le, G.,Jones, E.D.,Smith, J.A.,Coates, J.A.,Winfield, L.J.,Thienthong, N.,Newman, J.,Lucent, D.,Ryan, J.H.,Savage, G.P.,Francis, C.L.,Deadman, J.J.
Structural basis for a new mechanism of inhibition of HIV-1 integrase identified by fragment screening and structure-based design
ANTIVIR.CHEM.CHEMOTHER., 21:155-168, 2011

PubMed Abstract: HIV-1 integrase is a clinically validated therapeutic target for the treatment of HIV-1 infection, with one approved therapeutic currently on the market. This enzyme represents an attractive target for the development of new inhibitors to HIV-1 that are effective against the current resistance mutations.

PubMed: 21602613
DOI: 10.3851/IMP1716

実験手法

X-RAY DIFFRACTION (1.95 Å)